Molecule2 diseases

NLRP3 inflammasome

Central innate immune sensor driving caspase-1 activation and IL-1β/IL-18 maturation

Expression change
Overexpressed and hyperactivated
Evidence level
established

Expression across diseases

DiseaseRoleExpressionEvidence
Adult-Onset Still's DiseaseCentral innate immune sensor driving caspase-1 activation and IL-1β/IL-18 maturationOverexpressed and hyperactivatedestablished
TNF Receptor-Associated Periodic SyndromeInflammasome sensor — activated by mitochondrial ROSHyperactivatedstrong

Role in pathogenesis

The NLRP3 inflammasome is excessively activated in AOSD patients. Upon stimulation by DAMPs and PAMPs through TLRs, NLRP3 recruits ASC adaptor proteins and activates caspase-1, which cleaves pro-IL-1β and pro-IL-18 into bioactive forms. NLRP3, caspase-1, and IL-1β expression are all significantly elevated in PBMCs from AOSD patients. NLRP3 inhibition reduces IL-1β and IL-18 protein expression in AOSD PBMCs.

Sources (3)

DetailsFeist E et al. (2018) Mechanisms, biomarkers and targets for adult-onset Still's diseasePubMed
DetailsChen DY et al. (2017) Elevated expression of the NLRP3 inflammasome and its correlation with disease activity in adult-onset Still diseasePubMed
DetailsFautrel B et al. (2020) Adult-onset Still's diseasePubMed